Gut microbiota and metabolite interface-mediated hepatic inflammation

Area of Science:

• Microbiology
• Immunology
• Hepatology
• Metabolism

Background:

• The gut microbiota and its metabolites play a crucial role in the bidirectional communication between the gut and liver.
• Gut microbiota dysbiosis, influenced by diet, lifestyle, and genetics, is implicated in the progression of chronic liver disease.
• Commensal gut bacteria exert both pro- and anti-inflammatory effects, impacting liver inflammation.

Purpose of the Study:

• To review recent findings on bacterial species and metabolites that regulate liver inflammation.
• To discuss factors shaping gut microbiota and their impact on liver inflammation.
• To examine clinical trials targeting gut microbiota for liver disease treatment.

Main Methods:

• Literature review of recent scientific findings.
• Analysis of studies on gut microbiota composition and function.
• Review of clinical trials investigating microbiota-based therapies.

Main Results:

• Specific gut bacteria and their metabolites modulate hepatic immune and parenchymal cells, influencing liver inflammation.
• Socioeconomic, environmental, hormonal, and genetic factors shape gut microbiota profiles, affecting liver inflammation.
• Clinical trials are exploring interventions to manipulate gut microbiota for treating liver inflammation and chronic liver disease.

Conclusions:

• Microbial and metabolic mediators of the gut microbiota are critical in liver inflammation.
• Further research into these mediators will guide future studies and therapeutic strategies for liver disease.
• Targeting the gut microbiota holds promise for managing chronic liver conditions.